2006
DOI: 10.1002/cncr.22167
|View full text |Cite
|
Sign up to set email alerts
|

Applicability of the Bethesda System 2001 to a public health setting

Abstract: BACKGROUND The degree of applicability of the Bethesda System 2001 (TBS 2001) for cervicovaginal cytology to a public health setting is unknown, and extrapolations from available data are unwarranted. METHODS A “before/after” study design was used to evaluate the impact of TBS 2001 on an organized, population‐based screening program in northern Italy. Between 2003–2004, 6 cytology laboratories converted from TBS 1991 to TBS 2001. A set of screening indicators based on TBS 2001 (85,012 patients) were compared w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 19 publications
0
13
0
Order By: Relevance
“…Results were examined by optical microscopy and cytological diagnosis was in accordance with The Bethesda System (TBS, 2001) (10). …”
Section: Methodsmentioning
confidence: 99%
“…Results were examined by optical microscopy and cytological diagnosis was in accordance with The Bethesda System (TBS, 2001) (10). …”
Section: Methodsmentioning
confidence: 99%
“…(1.99%) in a screened population in Italy [24], possibly due to the more frequent occurrence of vaginal/cervical infections in inmate women. Because one out of the…”
Section: Discussionmentioning
confidence: 97%
“…ASC results also decreased in a report from a large European public health screening program. 40 The revisions associated with TBS 2001 occurred concurrently with a new effort to coordinate development of uniform guidelines to direct follow-up of patients with abnormal Pap tests. Interim management guidelines had been published in 1994 which encouraged colposcopy and directed biopsy for all women with LSIL, in addition to those with HSIL, because it was not possible to distinguish the lesions would progress to invasive cancer and which would regress.…”
Section: Henry Kissingermentioning
confidence: 99%